{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:47:33Z","timestamp":1787982453390,"version":"build-2784847793"},"reference-count":27,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.vaccine.2015.09.039","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T19:46:04Z","timestamp":1445802364000},"page":"6816-6822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial"],"prefix":"10.1016","volume":"33","author":[{"given":"Abhijeet","family":"Anand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepci\u00f3n F.","family":"Est\u00edvariz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Yunus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard E.","family":"Gary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Weldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tajul I.","family":"Bari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Steven Oberste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Wassilak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Luby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Heffelfinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Pallansch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.09.039_bib0140","series-title":"Vaccines","first-page":"1576","article-title":"Poliovirus vaccine-live","author":"Sutter","year":"2012"},{"issue":"March 12","key":"10.1016\/j.vaccine.2015.09.039_bib0145","first-page":"222","article-title":"Apparent global interruption of wild poliovirus type 2 transmission","volume":"50","author":"Centers for Disease Control Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkl Rep"},{"key":"10.1016\/j.vaccine.2015.09.039_bib0150","series-title":"Circulating vaccine-derived poliovirus","author":"The Global Polio Eradication Initiative","year":"2014"},{"key":"10.1016\/j.vaccine.2015.09.039_bib0155","first-page":"201","article-title":"Meeting of the strategic advisory group of experts on immunization april 2013 \u2013 conclusions and recommendations","volume":"88","author":"World Health Organization","year":"2013","journal-title":"Wkly Epidemiol Rec"},{"issue":"50","key":"10.1016\/j.vaccine.2015.09.039_bib0160","first-page":"561","article-title":"Meeting of the strategic advisory group of experts on immunization october 2014 \u2013 conclusions and recommendations","volume":"89","author":"World Health Organization","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"issue":"November (Suppl. 1)","key":"10.1016\/j.vaccine.2015.09.039_bib0165","doi-asserted-by":"crossref","first-page":"S465","DOI":"10.1093\/infdis\/jiu343","article-title":"Estimating the likely coverage of inactivated poliovirus vaccine in routine immunization: evidence from demographic and health surveys","volume":"210","author":"Anand","year":"2014","journal-title":"J Infect Dis"},{"issue":"January (5)","key":"10.1016\/j.vaccine.2015.09.039_bib0170","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa1202541","article-title":"Priming after a fractional dose of inactivated poliovirus vaccine","volume":"368","author":"Resik","year":"2013","journal-title":"N. Engl J Med"},{"key":"10.1016\/j.vaccine.2015.09.039_bib0175","series-title":"Meeting of the strategic advisory group of experts on immunization, april 2012 \u2013 conclusions and recommendations, The Weekly Epidemiological Record","first-page":"201","author":"World Health Organization","year":"2012"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2015.09.039_bib0180","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.vaccine.2008.10.077","article-title":"Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults","volume":"27","author":"Van Damme","year":"2009","journal-title":"Vaccine"},{"issue":"April (17)","key":"10.1016\/j.vaccine.2015.09.039_bib0185","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.vaccine.2011.12.069","article-title":"Quantitative and qualitative analysis of antibody response after dose sparing intradermal 2009 H1N1 vaccination","volume":"30","author":"Hung","year":"2012","journal-title":"Vaccine"},{"issue":"October (45)","key":"10.1016\/j.vaccine.2015.09.039_bib0190","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.1016\/j.vaccine.2012.08.014","article-title":"Dose sparing intradermal trivalent influenza (2010\/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain","volume":"30","author":"Hung","year":"2012","journal-title":"Vaccine"},{"issue":"July (34)","key":"10.1016\/j.vaccine.2015.09.039_bib0195","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1016\/j.vaccine.2014.03.024","article-title":"Clinical evaluation of a novel microneedle device for intradermal delivery of an influenza vaccine: are all delivery methods the same?","volume":"32","author":"Levin","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.09.039_bib0200","series-title":"Polio laboratory manual","author":"World Health Organization","year":"2004"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2015.09.039_bib0205","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1086\/651611","article-title":"Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba","volume":"201","author":"Resik","year":"2010","journal-title":"J Infect Dis"},{"issue":"November (9753)","key":"10.1016\/j.vaccine.2015.09.039_bib0210","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(10)61230-5","article-title":"Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial","volume":"376","author":"Sutter","year":"2010","journal-title":"Lancet"},{"issue":"February (9)","key":"10.1016\/j.vaccine.2015.09.039_bib0215","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.vaccine.2008.12.059","article-title":"Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age","volume":"27","author":"Zaman","year":"2009","journal-title":"Vaccine"},{"issue":"April (15)","key":"10.1016\/j.vaccine.2015.09.039_bib0220","first-page":"1536","article-title":"Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba","volume":"356","author":"The Cuba IPV Study Collaborative Group","year":"2007","journal-title":"N Engl J Med"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2015.09.039_bib0225","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0092-1157(83)80031-6","article-title":"Poliovirus and polio antibody assay in HEp-2 and Vero cell cultures","volume":"11","author":"Albrecht","year":"1983","journal-title":"J Biol Stand"},{"issue":"September (3 Pt 2)","key":"10.1016\/j.vaccine.2015.09.039_bib0230","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1542\/peds.96.3.600","article-title":"The reverse cumulative distribution plot: a graphic method for exploratory analysis of antibody data","volume":"96","author":"Reed","year":"1995","journal-title":"Pediatrics"},{"issue":"April (9570)","key":"10.1016\/j.vaccine.2015.09.039_bib0235","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0140-6736(07)60531-5","article-title":"Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study","volume":"369","author":"Grassly","year":"2007","journal-title":"Lancet"},{"issue":"August (9840)","key":"10.1016\/j.vaccine.2015.09.039_bib0240","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(12)60648-5","article-title":"The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001\u201311: a retrospective analysis","volume":"380","author":"O\u2019Reilly","year":"2012","journal-title":"Lancet"},{"issue":"May 5","key":"10.1016\/j.vaccine.2015.09.039_bib0245","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/infdis\/171.5.1097","article-title":"Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine","volume":"171","author":"World Health Organization Collaborative Study Group","year":"1995","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2015.09.039_bib0250","first-page":"253","article-title":"Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in the Gambia Oman, and Thailand","volume":"74","author":"WHO Collaborative Study Group","year":"1996","journal-title":"Bull World Health Org"},{"issue":"September\u2013October (5)","key":"10.1016\/j.vaccine.2015.09.039_bib0255","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/clinids\/13.5.926","article-title":"Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review","volume":"13","author":"Patriarca","year":"1991","journal-title":"Rev Infect Dis"},{"issue":"June (25)","key":"10.1016\/j.vaccine.2015.09.039_bib0260","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1056\/NEJMoa0909383","article-title":"Fractional doses of inactivated poliovirus vaccine in Oman","volume":"362","author":"Mohammed","year":"2010","journal-title":"N Engl J Med"},{"issue":"February (Suppl. 1)","key":"10.1016\/j.vaccine.2015.09.039_bib0265","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1093\/infdis\/175.Supplement_1.S228","article-title":"Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group","volume":"175","author":"Modlin","year":"1997","journal-title":"J Infect Dis"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2015.09.039_bib0270","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/oxfordjournals.aje.a009924","article-title":"Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative","volume":"150","author":"Fine","year":"1999","journal-title":"Am J Epidemiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15013158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15013158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T04:56:03Z","timestamp":1653368163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15013158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":27,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0264410X15013158"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.09.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.09.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}